Recombinant Human CAPG, None tagged

• Cat.No.: CAPG-203H
• Product Overview: Recombinant Human CAPG (AAH14549.1) (Met1-Lys348), fused with None, was produced in E. coli.

Specification

• Source: E. coli
• Species: Human
• Tag: None
• Predicted N Terminal: Met
• Form: Lyophilized from sterile 20mM tris, 10% glycerol, pH 8.0.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
• Molecular Mass: The recombinant human CAPG consists of 348 amino acids and predicts a molecular mass of 38.5 KDa. It migrates as an approximately 43 KDa band in SDS-PAGE under reducing conditions.
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >95 % as determined by SDS-PAGE
• Stability: Samples are stable for up to twelve months from date of receipt at -70oC.
• Storage: Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Gene Name: CAPG capping protein (actin filament), gelsolin-like [ Homo sapiens ]
• Official Symbol: CAPG
• Gene ID: 822
• mRNA Refseq: NM_001256139
• Protein Refseq: NP_001243068
• MIM: 153615
• UniProt ID: P40121
• Chromosome Location: 2p11.2